Author:
Kim Mira,Chae Kyung-Hee,Chung Youn-Jee,Hwang HyeJin,Lee MinKyung,Kim Hyun-Kyung,Cho Hyun-Hee,Kim Mee-Ran,Jung Chai-Young,Kim Sukil
Abstract
Abstract
Background
The look-back period is needed to define baseline population for estimating incidence. However, short look-back period is known to overestimate incidence of diseases misclassifying prevalent cases to incident cases. The purpose of this study is to evaluate the impact of the various length of look-back period on the observed incidences of uterine leiomyoma, endometriosis and adenomyosis, and to estimate true incidences considering the misclassification errors in the longitudinal administrative data in Korea.
Methods
A total of 319,608 women between 15 to 54 years of age in 2002 were selected from Korea National Health Insurance Services (KNHIS) cohort database. In order to minimize misclassification bias incurred when applying various length of look-back period, we used 11 years of claim data to estimate the incidence by equally setting the look-back period to 11 years for each year using prediction model. The association between the year of diagnosis and the number of prevalent cases with the misclassification rates by each look-back period was investigated. Based on the findings, prediction models on the proportion of misclassified incident cases were developed using multiple linear regression.
Results
The proportion of misclassified incident cases of uterine leiomyoma, endometriosis and adenomyosis were 32.8, 10.4 and 13.6% respectively for the one-year look-back period in 2003. These numbers decreased to 6.3% in uterine leiomyoma and − 0.8% in both endometriosis and adenomyosis using all available look-back periods (11 years) in 2013.
Conclusion
This study demonstrates approaches for estimating incidences considering the different proportion of misclassified cases for various length of look-back period. Although the prediction model used for estimation showed strong R-squared values, follow-up studies are required for validation of the study results.
Funder
Korea Health Industry Development Institute
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Trifiro G, Sultana J, Bate A. From big data to smart data for Pharmacovigilance: the role of healthcare databases and other emerging sources. Drug Saf. 2017.
2. Gothe H, et al. The use of administrative data to determine prevalence and incidence of Copd: a systematic review. Value Health. 2016;19(7):A368–9.
3. Widdifield J, et al. Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada. Multiple Scler. 2015;21(8):1045.
4. Ng, R., et al. Brain disorders in Ontario: prevalence, incidence and costs from health administrative data. Institute for Clinical Evaluative Sciences: Toronto, Ontario, 2015.
5. Nigwekar SU, et al. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014;29(3):724–31.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献